HAE
Haemonetics Corporation
NYSE
People also watch:ICUIIVCCNMDIARTCOO
29.610.21 (0.71%)

After hours: 29.610.00 (0.00%) as of 5:18 PM EDT

Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Prev Close29.40
Open29.37
Bid29.60 x 800
Ask29.61 x 600
52wk Range25.98 - 40.69
Day's Range29.27 - 29.73
Volume400,591
Avg Vol (3m)452,669
As of 4:02 PM EDT. Market closed.
  • Capital Cube13 hours ago

    Haemonetics Corp. :HAE-US: Earnings Analysis: 2016 By the Numbers : July 26, 2016

    Click here to see latest analysisHaemonetics Corp. reports financial results for the year ended March 31, 2016.We analyze the earnings along side the following peers of Haemonetics Corp. – Stryker Corporation and Medtronic Plc (SYK-US and MDT-US) that have also reported for this period.HighlightsGross margins narrowed from 47.72% to 45.73% compared to the same period […] (Read more...) The post Haemonetics Corp. :HAE-US: Earnings Analysis: 2016 By the Numbers : July 26, 2016 appeared first on CapitalCube.

  • Haemonetics Corp. – Value Analysis (NYSE:HAE) : July 5, 2016
    Capital Cube21 days ago

    Haemonetics Corp. – Value Analysis (NYSE:HAE) : July 5, 2016

    Click here to see latest analysisCapitalcube gives Haemonetics Corp. a score of 19.Our analysis is based on comparing Haemonetics Corp. with the following peers – Thermo Fisher Scientific Inc., Stryker Corporation, Becton, Dickinson and Company, Cerus Corporation, C. R. Bard, Inc., Baxter International Inc., PerkinElmer, Inc., Cytori Therapeutics, Inc., Medtronic Plc and HemaCare Corporation (TMO-US, […] (Read more...) The post Haemonetics Corp. – Value Analysis (NYSE:HAE) : July 5, 2016 appeared first on CapitalCube.